Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Bryan Haugen

Concepts (505)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
96
2025
337
16.740
 Why?
Iodine Radioisotopes
29
2025
145
3.820
 Why?
Thyroid Nodule
18
2025
56
3.730
 Why?
Adenocarcinoma, Follicular
19
2024
36
3.640
 Why?
Carcinoma, Papillary
24
2017
81
3.490
 Why?
Thyroid Gland
26
2018
94
3.360
 Why?
Endocrinology
10
2020
79
3.080
 Why?
Thyrotropin
30
2023
114
2.750
 Why?
Carcinoma
10
2025
236
1.820
 Why?
Thyroid Diseases
8
2020
36
1.480
 Why?
Thyroidectomy
17
2024
106
1.400
 Why?
Retinoid X Receptors
11
2011
39
1.290
 Why?
Antineoplastic Agents
15
2022
2129
1.270
 Why?
Retinoids
7
2011
33
1.210
 Why?
Tetrahydronaphthalenes
6
2015
29
1.180
 Why?
Hypothyroidism
8
2023
71
1.180
 Why?
Thyroid Carcinoma, Anaplastic
6
2019
34
1.160
 Why?
Carcinoma, Neuroendocrine
2
2025
42
1.080
 Why?
Thyroxine
12
2023
62
1.070
 Why?
Biomarkers, Tumor
15
2024
1274
1.050
 Why?
Receptors, Retinoic Acid
7
2004
42
1.030
 Why?
Biopsy, Fine-Needle
9
2021
68
0.960
 Why?
Carcinoma, Medullary
2
2025
17
0.960
 Why?
NF-kappa B
3
2015
691
0.940
 Why?
Carcinoma, Papillary, Follicular
4
2014
8
0.890
 Why?
Lymphatic Metastasis
7
2024
350
0.890
 Why?
Ultrasonography
8
2025
751
0.890
 Why?
Neoplasm Proteins
6
2013
432
0.840
 Why?
Transcription Factors
15
2014
1714
0.830
 Why?
Cell Line, Tumor
20
2023
3399
0.810
 Why?
Thyroglobulin
8
2024
27
0.810
 Why?
Gene Expression Profiling
6
2020
1768
0.810
 Why?
Humans
137
2025
136783
0.790
 Why?
Struma Ovarii
2
2014
7
0.770
 Why?
Radiopharmaceuticals
3
2012
178
0.770
 Why?
Proto-Oncogene Proteins B-raf
3
2023
226
0.700
 Why?
Thiazolidinediones
4
2018
137
0.690
 Why?
Neoplasm Invasiveness
6
2017
507
0.690
 Why?
Pituitary Gland
6
2011
149
0.680
 Why?
Promoter Regions, Genetic
14
2018
1250
0.680
 Why?
Thyroid Hormones
5
2023
61
0.670
 Why?
History, 20th Century
7
2018
323
0.660
 Why?
Oncogene Proteins, Fusion
2
2019
214
0.650
 Why?
Lymph Nodes
5
2018
492
0.640
 Why?
Cell Differentiation
5
2020
1980
0.610
 Why?
T-Lymphocytes, Regulatory
3
2015
387
0.600
 Why?
Triiodothyronine
4
2017
43
0.590
 Why?
Neoplasm Metastasis
10
2015
654
0.580
 Why?
Neoplasm Recurrence, Local
8
2024
1055
0.580
 Why?
History, 21st Century
6
2018
211
0.570
 Why?
Hypothalamus
2
2011
153
0.570
 Why?
Proto-Oncogene Proteins p21(ras)
1
2019
267
0.550
 Why?
Recombinant Proteins
9
2009
1354
0.530
 Why?
Programmed Cell Death 1 Receptor
3
2016
250
0.530
 Why?
Societies, Medical
6
2020
820
0.530
 Why?
Mutation
11
2023
3953
0.530
 Why?
Drug Resistance, Neoplasm
4
2023
800
0.520
 Why?
Neoplasm Staging
14
2021
1373
0.510
 Why?
Multimodal Imaging
2
2014
116
0.510
 Why?
Molecular Targeted Therapy
3
2015
413
0.500
 Why?
Ovarian Neoplasms
2
2014
563
0.500
 Why?
Pharmacogenomic Testing
1
2016
64
0.500
 Why?
Transcriptome
3
2020
971
0.480
 Why?
Protein-Tyrosine Kinases
1
2019
434
0.480
 Why?
DNA-Binding Proteins
13
2014
1500
0.480
 Why?
Terminology as Topic
1
2017
216
0.470
 Why?
Databases, Genetic
1
2016
236
0.470
 Why?
Famous Persons
1
2014
7
0.460
 Why?
Tomography, Emission-Computed, Single-Photon
2
2014
81
0.450
 Why?
Anticarcinogenic Agents
1
2015
77
0.450
 Why?
Physician Executives
1
2014
31
0.450
 Why?
Reverse Transcriptase Polymerase Chain Reaction
9
2014
973
0.440
 Why?
Mice
29
2023
17731
0.440
 Why?
Data Collection
3
2016
664
0.440
 Why?
Hyperthyroidism
2
2012
22
0.440
 Why?
Immunotherapy, Adoptive
1
2017
324
0.430
 Why?
Gene Expression Regulation, Neoplastic
7
2018
1396
0.430
 Why?
Genes, Tumor Suppressor
1
2014
86
0.430
 Why?
Neoplasm Transplantation
5
2019
256
0.430
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1683
0.420
 Why?
Gene Expression
2
2012
1499
0.420
 Why?
Combined Modality Therapy
8
2021
1235
0.420
 Why?
Medical Oncology
1
2016
290
0.410
 Why?
Interleukin-8
1
2014
267
0.400
 Why?
Cell Proliferation
10
2023
2473
0.400
 Why?
Phenylurea Compounds
2
2024
95
0.390
 Why?
Research
1
2016
445
0.390
 Why?
Neovascularization, Pathologic
1
2014
301
0.380
 Why?
Middle Aged
36
2024
33200
0.380
 Why?
Proteomics
3
2010
1108
0.380
 Why?
Pituitary Gland, Anterior
4
2002
38
0.380
 Why?
Quinolines
2
2024
177
0.380
 Why?
Radiotherapy, Adjuvant
2
2012
217
0.380
 Why?
RNA, Messenger
15
2012
2831
0.370
 Why?
Female
53
2024
72840
0.370
 Why?
Animals
33
2023
36768
0.370
 Why?
Decision Support Techniques
1
2015
418
0.360
 Why?
Bone Neoplasms
2
2012
248
0.350
 Why?
Practice Guidelines as Topic
5
2020
1568
0.350
 Why?
Protein Kinase Inhibitors
3
2024
916
0.350
 Why?
Telomerase
5
2019
250
0.340
 Why?
DNA, Neoplasm
2
2008
164
0.340
 Why?
Prognosis
12
2024
4018
0.340
 Why?
Blotting, Western
8
2014
1225
0.330
 Why?
PPAR gamma
3
2009
182
0.330
 Why?
Aged
25
2024
23729
0.330
 Why?
Male
46
2024
67361
0.330
 Why?
Carrier Proteins
1
2014
768
0.320
 Why?
MAP Kinase Kinase 2
1
2009
28
0.320
 Why?
T-Lymphocytes
2
2017
1998
0.320
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2009
11
0.310
 Why?
Cell Culture Techniques
2
2009
363
0.310
 Why?
MAP Kinase Kinase 1
1
2009
75
0.310
 Why?
Forkhead Transcription Factors
1
2010
190
0.310
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2009
34
0.310
 Why?
Iodide Peroxidase
2
2005
28
0.290
 Why?
Signal Transduction
6
2023
5065
0.290
 Why?
Treatment Outcome
18
2024
10764
0.290
 Why?
Hormone Replacement Therapy
2
2020
96
0.290
 Why?
Benzodioxoles
1
2009
115
0.280
 Why?
Receptors, Cytoplasmic and Nuclear
2
2009
219
0.280
 Why?
Adult
34
2024
37616
0.280
 Why?
Quinazolines
1
2009
249
0.280
 Why?
Cell Transformation, Neoplastic
2
2012
326
0.270
 Why?
MAP Kinase Signaling System
1
2009
321
0.270
 Why?
Adenoma
3
2025
230
0.260
 Why?
S100 Proteins
1
2006
37
0.260
 Why?
Retrospective Studies
12
2025
15564
0.260
 Why?
Adenoma, Oxyphilic
2
2024
7
0.260
 Why?
Disease-Free Survival
5
2021
687
0.260
 Why?
Diagnosis, Differential
6
2025
1483
0.250
 Why?
Lipoprotein Lipase
2
2004
59
0.250
 Why?
Apoptosis
4
2012
2548
0.250
 Why?
Tamoxifen
3
2023
202
0.250
 Why?
Evidence-Based Medicine
3
2020
738
0.240
 Why?
Molecular Diagnostic Techniques
2
2021
104
0.240
 Why?
Tomography, X-Ray Computed
3
2018
2677
0.240
 Why?
Mice, Nude
5
2018
692
0.240
 Why?
Oligonucleotide Array Sequence Analysis
3
2014
765
0.240
 Why?
Neoplasms
3
2016
2644
0.240
 Why?
Melanoma
2
2009
757
0.230
 Why?
Tumor Cells, Cultured
8
2009
953
0.230
 Why?
Goiter, Nodular
1
2004
2
0.230
 Why?
Retinoid X Receptor gamma
1
2004
4
0.230
 Why?
Galectin 3
1
2004
21
0.230
 Why?
Chromosomal Proteins, Non-Histone
2
2002
126
0.220
 Why?
Sensitivity and Specificity
6
2024
1942
0.220
 Why?
Dietary Fats
2
2004
303
0.220
 Why?
Microtubule-Associated Proteins
2
2002
195
0.220
 Why?
Immunohistochemistry
7
2020
1731
0.210
 Why?
United States
13
2023
14660
0.210
 Why?
Radionuclide Imaging
4
2010
118
0.210
 Why?
Cell Cycle
2
2023
601
0.210
 Why?
Molecular Sequence Data
13
2006
2903
0.210
 Why?
Drug Resistance
2
2022
169
0.210
 Why?
Whole-Body Counting
2
2006
6
0.210
 Why?
Cell Line
4
2022
2836
0.210
 Why?
Prospective Studies
12
2023
7583
0.200
 Why?
Cell Cycle Proteins
1
2006
611
0.190
 Why?
Aged, 80 and over
10
2024
7569
0.190
 Why?
Benzoates
3
2009
43
0.190
 Why?
Estrogen Receptor alpha
1
2023
145
0.190
 Why?
Reoperation
1
2024
565
0.190
 Why?
Disease Models, Animal
4
2022
4279
0.190
 Why?
Cytodiagnosis
1
2021
33
0.180
 Why?
Xenograft Model Antitumor Assays
4
2020
864
0.170
 Why?
Thyroid Hormone Resistance Syndrome
1
2000
1
0.170
 Why?
Lymphoma
1
2002
206
0.170
 Why?
Polymorphism, Single Nucleotide
1
2008
2190
0.170
 Why?
Estrogens
1
2023
367
0.170
 Why?
Base Sequence
11
2002
2180
0.170
 Why?
Breast Neoplasms
3
2023
2239
0.170
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
3
2010
144
0.160
 Why?
Consensus
3
2020
679
0.160
 Why?
Adenocarcinoma
3
2017
936
0.160
 Why?
CD8-Positive T-Lymphocytes
3
2016
913
0.160
 Why?
Vascular Endothelial Growth Factor A
1
2022
544
0.150
 Why?
Nitriles
2
2010
172
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2024
804
0.150
 Why?
Transfection
5
2005
945
0.150
 Why?
Thyrotropin, beta Subunit
2
2011
5
0.140
 Why?
Receptors, Estrogen
1
2020
436
0.140
 Why?
Up-Regulation
1
2020
843
0.140
 Why?
Antigens, Neoplasm
1
2020
320
0.140
 Why?
Algorithms
5
2018
1686
0.140
 Why?
Workflow
1
2018
165
0.140
 Why?
Neck
2
2015
101
0.140
 Why?
Intercellular Adhesion Molecule-1
1
2017
139
0.140
 Why?
Tissue Extracts
1
2017
19
0.140
 Why?
Heterografts
2
2015
138
0.130
 Why?
Disease Progression
6
2020
2750
0.130
 Why?
Transcription Factor Pit-1
8
1999
27
0.130
 Why?
Parathyroidectomy
1
2016
9
0.130
 Why?
Muscle, Skeletal
2
2004
1707
0.130
 Why?
Tretinoin
1
1997
123
0.130
 Why?
Enzyme Inhibitors
2
2010
838
0.130
 Why?
Homeodomain Proteins
3
1999
504
0.120
 Why?
Colorado
3
2014
4491
0.120
 Why?
Caspase 7
1
2015
22
0.120
 Why?
Prolactin
2
1999
97
0.120
 Why?
Ligands
3
2009
664
0.120
 Why?
Hypocalcemia
1
2015
27
0.120
 Why?
Bortezomib
1
2015
54
0.120
 Why?
Larynx
1
2016
60
0.120
 Why?
Information Storage and Retrieval
1
2016
117
0.120
 Why?
Inhibitory Concentration 50
1
2015
90
0.120
 Why?
Diet
1
2023
1273
0.120
 Why?
User-Computer Interface
1
2016
157
0.120
 Why?
Radiation, Ionizing
1
2015
81
0.120
 Why?
Taxoids
1
2015
104
0.120
 Why?
Pharmacogenetics
1
2016
179
0.120
 Why?
Laryngoscopy
1
2016
109
0.120
 Why?
Risk Assessment
4
2024
3429
0.120
 Why?
Transcriptional Activation
2
1994
378
0.110
 Why?
Double-Blind Method
2
2012
1981
0.110
 Why?
Tumor Suppressor Protein p53
1
2019
530
0.110
 Why?
Immunophenotyping
2
2015
319
0.110
 Why?
Guidelines as Topic
1
2016
276
0.110
 Why?
Societies, Scientific
1
2014
51
0.110
 Why?
Caspase 3
1
2015
246
0.110
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
251
0.110
 Why?
Growth Hormone
1
1994
101
0.110
 Why?
NF-KappaB Inhibitor alpha
1
2014
54
0.110
 Why?
Immunotherapy
2
2016
640
0.110
 Why?
Energy Metabolism
1
2000
918
0.110
 Why?
Predictive Value of Tests
2
2019
2030
0.110
 Why?
DNA Mutational Analysis
2
2020
400
0.110
 Why?
Histiocytoma, Benign Fibrous
1
1994
8
0.110
 Why?
Lymphocytes, Tumor-Infiltrating
1
2016
209
0.110
 Why?
Diagnostic Techniques, Endocrine
1
2013
14
0.110
 Why?
Graves Disease
2
2012
34
0.110
 Why?
I-kappa B Proteins
1
2014
81
0.110
 Why?
ROC Curve
1
2015
545
0.110
 Why?
Cell Death
1
2015
370
0.110
 Why?
Transduction, Genetic
1
2014
126
0.110
 Why?
Preoperative Care
3
2024
356
0.110
 Why?
Stilbenes
1
2013
36
0.100
 Why?
Human Umbilical Vein Endothelial Cells
1
2014
104
0.100
 Why?
Drug Resistance, Multiple
1
2013
25
0.100
 Why?
Young Adult
6
2024
13126
0.100
 Why?
Registries
6
2015
2015
0.100
 Why?
Transcription, Genetic
5
2011
1453
0.100
 Why?
Genetic Variation
1
2018
985
0.100
 Why?
Observer Variation
1
2013
345
0.100
 Why?
Sirolimus
1
2014
275
0.100
 Why?
Contraindications
1
2012
90
0.100
 Why?
Nuclear Proteins
1
1997
710
0.090
 Why?
T-Lymphocyte Subsets
2
2015
425
0.090
 Why?
Thiazoles
1
2012
123
0.090
 Why?
Receptors, Thyroid Hormone
3
1996
21
0.090
 Why?
src-Family Kinases
1
2012
92
0.090
 Why?
Protein Isoforms
2
2004
400
0.090
 Why?
Thyroiditis, Autoimmune
2
2020
15
0.090
 Why?
Glycoprotein Hormones, alpha Subunit
1
2011
23
0.090
 Why?
Mice, 129 Strain
1
2011
88
0.090
 Why?
Genomics
1
2016
790
0.090
 Why?
TOR Serine-Threonine Kinases
1
2014
412
0.090
 Why?
Adolescent
7
2024
21463
0.090
 Why?
Oleanolic Acid
1
2010
9
0.080
 Why?
Polymerase Chain Reaction
4
2005
1059
0.080
 Why?
Whole Body Imaging
1
2010
25
0.080
 Why?
Cells, Cultured
3
2014
4194
0.080
 Why?
Quality Improvement
1
2018
1152
0.080
 Why?
Ribonucleases
3
2002
55
0.080
 Why?
Pilot Projects
1
2015
1697
0.080
 Why?
Weight Gain
2
2023
518
0.080
 Why?
Amino Acid Sequence
4
2006
2145
0.080
 Why?
Electrophoresis, Gel, Two-Dimensional
2
2008
114
0.080
 Why?
Somatostatin
1
2009
61
0.080
 Why?
Dopamine Agonists
1
2009
40
0.080
 Why?
Lymphocyte Subsets
1
2010
87
0.080
 Why?
Antibody Specificity
1
2010
189
0.080
 Why?
Lymphoma, T-Cell
1
2009
25
0.080
 Why?
Diphosphonates
1
2010
66
0.080
 Why?
Sulfones
1
2010
110
0.080
 Why?
Butadienes
1
2009
36
0.080
 Why?
Endometrial Neoplasms
2
2002
199
0.080
 Why?
Bone Density Conservation Agents
1
2010
80
0.080
 Why?
Calcium
1
2015
1197
0.080
 Why?
Hysterectomy
1
2010
128
0.080
 Why?
Radiotherapy
1
2010
201
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
193
0.080
 Why?
Postoperative Complications
2
2023
2624
0.070
 Why?
Time Factors
3
2010
6792
0.070
 Why?
Pyrimidines
1
2012
470
0.070
 Why?
Benzamides
1
2009
217
0.070
 Why?
Drug Evaluation, Preclinical
1
2009
182
0.070
 Why?
Membrane Proteins
1
2015
1162
0.070
 Why?
Phosphorylation
2
2012
1756
0.070
 Why?
Flow Cytometry
1
2012
1181
0.070
 Why?
CD4-Positive T-Lymphocytes
2
2015
1092
0.070
 Why?
Lymphocyte Activation
1
2012
1150
0.070
 Why?
Cohort Studies
5
2023
5718
0.070
 Why?
Enzyme Activation
1
2009
813
0.070
 Why?
Proportional Hazards Models
3
2023
1260
0.070
 Why?
Autoantibodies
2
2013
1500
0.070
 Why?
S100 Calcium Binding Protein A6
1
2006
1
0.070
 Why?
Phenotype
3
2015
3199
0.070
 Why?
Follow-Up Studies
5
2024
5115
0.060
 Why?
RNA, Small Interfering
1
2009
621
0.060
 Why?
Reproducibility of Results
2
2019
3272
0.060
 Why?
Colonic Neoplasms
1
2008
256
0.060
 Why?
Fatty Acids, Nonesterified
1
2006
159
0.060
 Why?
Metformin
1
2009
329
0.060
 Why?
Pituitary Neoplasms
2
1999
190
0.060
 Why?
Postoperative Care
2
2018
257
0.060
 Why?
Drug Delivery Systems
1
2009
362
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2006
121
0.060
 Why?
Neoplasm Grading
2
2018
306
0.060
 Why?
Chromatin Immunoprecipitation
1
2005
138
0.060
 Why?
Inhibitor of Apoptosis Proteins
2
2002
49
0.060
 Why?
RNA, Neoplasm
2
2002
82
0.060
 Why?
Glucocorticoids
1
2009
596
0.060
 Why?
Blotting, Southern
2
1996
72
0.060
 Why?
Brain Neoplasms
1
2014
1241
0.060
 Why?
Neck Dissection
1
2024
23
0.060
 Why?
Paclitaxel
1
2006
227
0.060
 Why?
Recurrent Laryngeal Nerve Injuries
1
2024
12
0.060
 Why?
Chromosome Mapping
2
1997
523
0.060
 Why?
Adjuvants, Pharmaceutic
1
2004
11
0.060
 Why?
Tomography, Emission-Computed
1
2004
66
0.060
 Why?
Organic Chemicals
1
2005
126
0.060
 Why?
Luciferases
1
2004
150
0.050
 Why?
DNA, Mitochondrial
1
2005
200
0.050
 Why?
Immunoprecipitation
1
2004
155
0.050
 Why?
Triglycerides
1
2006
524
0.050
 Why?
Heart Neoplasms
2
2015
52
0.050
 Why?
Probability
2
2021
309
0.050
 Why?
Cell Cycle Checkpoints
2
2016
98
0.050
 Why?
Quality of Life
3
2022
2868
0.050
 Why?
Dose-Response Relationship, Drug
2
2005
2045
0.050
 Why?
Lymph Node Excision
1
2024
170
0.050
 Why?
Professional Practice
1
2003
64
0.050
 Why?
Computers
1
2023
68
0.050
 Why?
National Institutes of Health (U.S.)
1
2023
128
0.050
 Why?
Genetic Testing
2
2018
452
0.050
 Why?
Protein Binding
1
2009
2223
0.050
 Why?
Poly A
1
2002
50
0.050
 Why?
5' Untranslated Regions
1
2002
57
0.050
 Why?
Gene Library
1
2002
117
0.050
 Why?
DNA, Complementary
1
2002
269
0.050
 Why?
Cell Division
1
2004
796
0.050
 Why?
Magnetic Resonance Imaging
2
2010
3566
0.050
 Why?
Point Mutation
1
2002
234
0.050
 Why?
Endometrium
1
2002
58
0.050
 Why?
Survival Analysis
3
2010
1319
0.050
 Why?
Thallium Radioisotopes
1
2001
8
0.050
 Why?
Organotechnetium Compounds
1
2001
10
0.050
 Why?
Thallium
1
2001
2
0.050
 Why?
Biopsy, Needle
1
2002
189
0.050
 Why?
Carcinoma, Endometrioid
1
2002
50
0.050
 Why?
Child
1
2021
21968
0.040
 Why?
Plasmids
1
2002
362
0.040
 Why?
Patient Care Management
1
2001
56
0.040
 Why?
Thyroid Function Tests
2
2017
14
0.040
 Why?
Life Style
1
2023
484
0.040
 Why?
Macrophages
2
2020
1541
0.040
 Why?
Health Status
1
2006
781
0.040
 Why?
MutS Homolog 2 Protein
1
2020
15
0.040
 Why?
MCF-7 Cells
1
2020
124
0.040
 Why?
Specialization
1
2001
143
0.040
 Why?
Calcitonin
1
2020
27
0.040
 Why?
Mice, Transgenic
1
2005
2162
0.040
 Why?
Models, Animal
1
2022
384
0.040
 Why?
Pituitary Hormones
1
1999
16
0.040
 Why?
Receptors, Virus
1
2020
83
0.040
 Why?
Mice, SCID
1
2020
367
0.040
 Why?
Medicine
1
2001
119
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2020
161
0.040
 Why?
Risk Factors
3
2023
10331
0.040
 Why?
Validation Studies as Topic
1
2019
22
0.040
 Why?
Singapore
1
2019
22
0.040
 Why?
Cost-Benefit Analysis
1
2022
584
0.040
 Why?
Octreotide
1
1999
26
0.040
 Why?
Lymphoma, T-Cell, Cutaneous
1
1999
43
0.040
 Why?
Immune System
1
2020
177
0.040
 Why?
Mice, Inbred NOD
1
2020
601
0.040
 Why?
Drug Therapy, Combination
1
2022
1059
0.040
 Why?
Leukocytes
1
2020
312
0.040
 Why?
Luminescence
1
2018
38
0.040
 Why?
Kaplan-Meier Estimate
1
2020
891
0.040
 Why?
Radiation Tolerance
1
1999
96
0.040
 Why?
Pharmacogenomic Variants
1
2018
35
0.040
 Why?
Surveys and Questionnaires
3
2020
5749
0.040
 Why?
DNA Mismatch Repair
1
2018
49
0.040
 Why?
North America
1
2018
313
0.040
 Why?
Age Factors
3
2015
3290
0.030
 Why?
Interdisciplinary Communication
1
2018
192
0.030
 Why?
Oncogenes
1
2018
116
0.030
 Why?
Dietary Carbohydrates
1
1998
154
0.030
 Why?
Delphi Technique
1
2018
273
0.030
 Why?
Liver
1
2005
1938
0.030
 Why?
Soft Tissue Neoplasms
1
2018
114
0.030
 Why?
Doxorubicin
1
1999
365
0.030
 Why?
Gene Frequency
1
2018
520
0.030
 Why?
Advisory Committees
1
2018
219
0.030
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
77
0.030
 Why?
Tissue Distribution
1
1997
329
0.030
 Why?
DNA
4
1996
1458
0.030
 Why?
Stroboscopy
1
2016
9
0.030
 Why?
Health Policy
1
2020
387
0.030
 Why?
DNA Fingerprinting
1
1996
26
0.030
 Why?
Deoxyribonuclease I
1
1996
39
0.030
 Why?
Immunomodulation
1
2016
97
0.030
 Why?
Tumor Suppressor Proteins
1
2018
327
0.030
 Why?
Antithyroid Agents
2
2006
13
0.030
 Why?
Surgeons
1
2020
296
0.030
 Why?
RNA
1
2002
924
0.030
 Why?
Clinical Trials as Topic
1
2020
1043
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
535
0.030
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2015
30
0.030
 Why?
Chromosomes, Human, Pair 4
1
1995
30
0.030
 Why?
Mutagenesis, Site-Directed
1
1996
376
0.030
 Why?
Lymphocyte Count
1
2015
150
0.030
 Why?
Mutagenesis, Insertional
1
1994
65
0.030
 Why?
Cytotoxicity, Immunologic
1
2015
225
0.030
 Why?
Adipose Tissue
1
1998
629
0.030
 Why?
Microsatellite Repeats
1
2014
167
0.030
 Why?
Gene Expression Regulation
4
1997
2603
0.030
 Why?
Age of Onset
1
2015
518
0.030
 Why?
Proto-Oncogene Proteins c-bcl-2
1
1995
233
0.030
 Why?
Risk
2
2006
904
0.030
 Why?
Mice, Knockout
1
2020
2999
0.030
 Why?
Genes, Neoplasm
1
2013
22
0.030
 Why?
Computational Biology
1
2018
645
0.030
 Why?
Killer Cells, Natural
1
2016
445
0.030
 Why?
Preoperative Period
1
2013
130
0.030
 Why?
Head and Neck Neoplasms
1
2018
604
0.030
 Why?
Gene Deletion
1
1994
392
0.030
 Why?
Neutropenia
1
2013
146
0.020
 Why?
Alternative Splicing
1
1994
227
0.020
 Why?
DNA, Single-Stranded
1
1993
118
0.020
 Why?
Case-Control Studies
2
2015
3537
0.020
 Why?
Postoperative Period
1
2013
343
0.020
 Why?
Focal Adhesion Kinase 1
1
2012
32
0.020
 Why?
Reference Values
2
2005
817
0.020
 Why?
Dasatinib
1
2012
54
0.020
 Why?
Genetic Markers
1
2013
344
0.020
 Why?
Recurrence
1
2015
1058
0.020
 Why?
Autophagy
1
2014
281
0.020
 Why?
Repressor Proteins
1
1995
424
0.020
 Why?
Age Distribution
1
2012
391
0.020
 Why?
Sex Distribution
1
2012
376
0.020
 Why?
Tumor Burden
1
2012
309
0.020
 Why?
Saccharomyces cerevisiae Proteins
1
1995
404
0.020
 Why?
Primary Health Care
1
2001
1714
0.020
 Why?
Longevity
1
2012
165
0.020
 Why?
Universities
1
2013
432
0.020
 Why?
Interleukin-6
1
2014
778
0.020
 Why?
Obesity
1
2023
2975
0.020
 Why?
Protein Processing, Post-Translational
1
2012
467
0.020
 Why?
Menopause
1
2012
318
0.020
 Why?
Cell Survival
1
2012
1117
0.020
 Why?
Cross-Sectional Studies
1
2020
5417
0.020
 Why?
Early Detection of Cancer
1
2013
419
0.020
 Why?
Calreticulin
1
2008
27
0.020
 Why?
Physical Examination
1
2009
241
0.020
 Why?
Exons
2
2002
349
0.020
 Why?
Binding Sites
3
1996
1308
0.020
 Why?
Insulin
1
1998
2399
0.020
 Why?
Drug Administration Schedule
1
2009
783
0.020
 Why?
Cytokines
1
2015
2088
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor Proteins
1
2006
7
0.020
 Why?
Chromans
1
2006
25
0.020
 Why?
Radiotherapy Dosage
1
2006
267
0.020
 Why?
International Cooperation
1
2006
198
0.010
 Why?
Feasibility Studies
1
2009
947
0.010
 Why?
Angiogenesis Inhibitors
1
2006
226
0.010
 Why?
Radiography
1
2006
829
0.010
 Why?
Inflammation
1
2014
2834
0.010
 Why?
Neoplasm, Residual
1
2003
133
0.010
 Why?
Culture Techniques
1
2002
81
0.010
 Why?
Biopsy
1
2006
1126
0.010
 Why?
Peptides
1
2008
980
0.010
 Why?
Models, Biological
1
2008
1769
0.010
 Why?
Pain
1
2006
755
0.010
 Why?
Fushi Tarazu Transcription Factors
1
1999
5
0.010
 Why?
Steroidogenic Factor 1
1
1999
12
0.010
 Why?
Gonadotropins
1
1999
40
0.010
 Why?
Postmenopause
1
2002
365
0.010
 Why?
Analysis of Variance
1
2002
1318
0.010
 Why?
DNA Primers
1
1999
513
0.010
 Why?
Follicle Stimulating Hormone
1
1999
244
0.010
 Why?
Organ Specificity
1
1998
304
0.010
 Why?
GATA2 Transcription Factor
1
1997
15
0.010
 Why?
Logistic Models
1
2002
2060
0.010
 Why?
Sequence Deletion
1
1996
183
0.010
 Why?
3T3 Cells
1
1995
163
0.010
 Why?
Muridae
1
1995
5
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
1995
113
0.010
 Why?
Replication Protein C
1
1995
4
0.010
 Why?
Hybrid Cells
1
1995
49
0.010
 Why?
Macromolecular Substances
1
1995
229
0.010
 Why?
Mutagenesis
1
1995
182
0.010
 Why?
Minor Histocompatibility Antigens
1
1995
48
0.010
 Why?
Mice, Inbred DBA
1
1994
200
0.010
 Why?
Body Weight
1
1998
981
0.010
 Why?
Survival Rate
1
1998
1969
0.010
 Why?
Cloning, Molecular
1
1994
534
0.010
 Why?
Blotting, Northern
1
1993
199
0.010
 Why?
Haplotypes
1
1995
490
0.010
 Why?
Sex Factors
1
1998
2068
0.010
 Why?
Protein Biosynthesis
1
1993
433
0.010
 Why?
Rats
1
1996
5628
0.000
 Why?
Mice, Inbred C57BL
1
1995
5744
0.000
 Why?
Haugen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (505) concept(s)
_
Co-Authors Expand Description
See all (46) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)